Larimar Therapeutics (LRMR) Assets Average: 2014-2020
Historic Assets Average for Larimar Therapeutics (LRMR) over the last 6 years, with Sep 2020 value amounting to $119.7 million.
- Larimar Therapeutics' Assets Average rose 21.67% to $119.7 million in Q3 2020 from the same period last year, while for Sep 2020 it was $119.7 million, marking a year-over-year increase of 21.67%. This contributed to the annual value of $63.5 million for FY2019, which is 44.14% down from last year.
- According to the latest figures from Q3 2020, Larimar Therapeutics' Assets Average is $119.7 million, which was up 20.21% from $99.6 million recorded in Q2 2020.
- In the past 5 years, Larimar Therapeutics' Assets Average registered a high of $179.6 million during Q1 2016, and its lowest value of $39.5 million during Q1 2020.
- Its 3-year average for Assets Average is $95.2 million, with a median of $99.6 million in 2020.
- As far as peak fluctuations go, Larimar Therapeutics' Assets Average increased by 25.74% in 2018, and later plummeted by 65.98% in 2020.
- Over the past 5 years, Larimar Therapeutics' Assets Average (Quarterly) stood at $137.2 million in 2016, then declined by 26.45% to $100.9 million in 2017, then increased by 25.74% to $126.9 million in 2018, then crashed by 61.34% to $49.0 million in 2019, then increased by 21.67% to $119.7 million in 2020.
- Its Assets Average stands at $119.7 million for Q3 2020, versus $99.6 million for Q2 2020 and $39.5 million for Q1 2020.